| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.9M | -68.6% |
| Cost of Revenue | $4.7M | +15.6% |
| Gross Profit | -$1.8M | -135.8% |
| R&D Expense | $14.0M | -19.2% |
| SG&A Expense | $16.5M | +52.6% |
| Operating Income | -$36.5M | -178.5% |
| Interest Expense | $6.0M | +55.8% |
| Pre-tax Income | -$42.5M | -255.9% |
| Income Tax | $902K | +102.7% |
| Net Income | -$43.4M | -250.4% |
| EPS (Basic) | -$0.82 | -173.3% |
| EPS (Diluted) | -$0.82 | -173.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $590K | -58.9% |
| Accounts Receivable | $2.6M | -54.8% |
| Inventory | $947K | -68.2% |
| Current Assets | $11.9M | -32.4% |
| Total Assets | $15.6M | -21.4% |
| Current Liabilities | $79.6M | +30.6% |
| Long-term Debt | $62.6M | +46.8% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$30.7M | +0.9% |
| Capital Expenditures | $2.4M | +344.8% |
| Investing Cash Flow | -$2.4M | -344.8% |
| Financing Cash Flow | $32.2M | -11.6% |
| Free Cash Flow | -$33.1M | -5.0% |
| $98.9M |
| +24.9% |
| Stockholders' Equity | -$83.3M | -40.4% |